The Anovo system. [Image from Momentis]Momentis Surgical (formerly Memic) announced today that it received FDA 510(k) clearance for its Anovo robotic surgical platform.

Anovo系统。[来自Momentis的图片]Momentis Surgical（前Memic）今天宣布，其Anovo机器人手术平台获得FDA 510（k）许可。

Anovo received clearance for use in single-site, abdominal access across ventral hernia repair. The clearance complements Anovo’s existing approvals for natural orifice laparoscopic-assisted transvaginal benign gynecology procedures.

Anovo获得许可，可用于单部位腹壁疝修补术。该许可补充了Anovo对自然孔腹腔镜辅助经阴道良性妇科手术的现有批准。

Momentis designed Anovo as a single-port robotics platform and clearance makes it the first such system cleared for this indication. The company says procedures performed through a single port with multiple flexible instruments could potentially result in less invasive and less traumatic outcomes for the tissue at point of entry..

Momentis将Anovo设计为一个单端口机器人平台，而clearance使其成为第一个获得此指示许可的此类系统。该公司表示，通过具有多个柔性仪器的单个端口进行的手术可能会在进入点对组织产生较小的侵入性和较小的创伤。。

The Anovo system, a small, portable robotic system, enables this. Its miniature humanoid-shaped robotic arms provide human-level dexterity, the company says. Momentis also developed it with multi-planar flexibility and 360 degrees of articulation. Its biomimetic instruments replicate the motions and capabilities of a surgeon’s arms, with shoulder, elbow and wrist joints..

Anovo系统是一种小型便携式机器人系统，可以实现这一点。该公司表示，它的微型仿人机器人手臂提供了人类水平的灵活性。Momentis还开发了多平面灵活性和360度关节。它的仿生仪器复制了外科医生手臂的运动和能力，包括肩关节、肘关节和腕关节。。

Dr. Fred Moll, a pioneer in surgical robotics and board member at Momentis, believes “the future of soft tissue robotics is flexible instruments.” He called Momentis’ technology “clearly differentiating” and capable of having an “immediate impact” on general surgery.

Fred Moll博士是Momentis外科机器人的先驱和董事会成员，他认为“软组织机器人的未来是灵活的仪器。”他称Momentis的技术“明显不同”，能够对普通外科产生“直接影响”。

“Leveraging the clinical achievements of our Anovo platform in gynecology and the connections we established with leading medical centers worldwide, we have seized the opportunity to expand to general surgery for our groundbreaking technology. Due to its size and mobility, our system can be used both in hospitals and outpatient settings, where most hernia surgeries can be performed, but are not currently, because of the limitations of existing robotic platforms,” said Dvir Cohen, CEO and co-founder of Momentis Surgical..

Momentis Surgical首席执行官兼联合创始人Dvir Cohen说：“利用我们在妇科领域的Anovo平台的临床成就以及我们与全球领先医疗中心建立的联系，我们抓住机会将开创性技术扩展到普通外科。由于其规模和移动性，我们的系统可以在医院和门诊环境中使用，大多数疝气手术都可以进行，但由于现有机器人平台的局限性，目前还没有。”。。

“Anovo’s unique features allow surgeons and patients access to robotic procedures outside the hospital by offering robotic technology to ambulatory surgical centers.”

“Anovo的独特功能为门诊手术中心提供机器人技术，使外科医生和患者能够在医院外进行机器人手术。”